Chiron Real Estate (XRN) Proxy Filing summary

Executive summary

• The annual meeting is scheduled for May 14, 2025, to be held virtually, with registration required by May 12, 2025.

• Key 2024 performance highlights include a decrease in short-term interest rates, a lower cost of debt, but a higher cost of equity due to a drop in stock price.

• The company acquired $80 million in healthcare facilities and entered into a contract for an additional $70 million, with some closings expected in early 2025.

• The board released its third Corporate Social Responsibility Report in June 2024, emphasizing sustainability and human capital initiatives.

Voting matters and shareholder proposals

• Shareholders will vote on electing seven directors, an advisory resolution on executive compensation, and ratification of Deloitte as the independent auditor for 2025.

• The board recommends voting FOR all proposals.

• Shareholders may submit proposals for the 2026 meeting by December 1, 2025, and director nominations must comply with bylaw notice requirements.

Board of directors and corporate governance

• The board consists of seven directors, with a majority being independent and all attending at least 75% of meetings in 2024.

• Four standing committees: Audit, Nominating and Corporate Governance, Compensation, and ESG, each with independent chairs.

• The board has a combined Chairman/CEO role, a Lead Independent Director, and equity ownership requirements for directors.

• Board leadership structure and risk oversight are regularly reviewed, with risk management integrated into decision-making.